about
The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependenceGroup III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans.Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus.Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.Delta-opioid receptor binding sites in rodent spinal cord.Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception.Evidence for an important role of protein phosphatases in the mechanism of morphine tolerancePre-treatment with a PKC or PKA inhibitor prevents the development of morphine tolerance but not physical dependence in mice.Autoradiographic localization of supraspinal kappa-opioid receptors with [125I-Tyr1, D-Pro10]dynorphin A-(1-11).Recent advances in the physiology and pharmacology of pain: plasticity and its implications for clinical analgesia.Opioid administration following spinal cord injury: implications for pain and locomotor recovery.The role of neuropeptides in the regulation of the micturition reflex.Spinal Reflexes and Windup In Vitro: Effects of Analgesics and Anesthetics.Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.Role of histamine in rodent antinociception.Limb movement-induced hyperemia has a central hemodynamic component: evidence from a neural blockade study.Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administrationBlockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the Antinociceptive Effect of Local Injections of Anandamide in MiceAnalgesic doses of morphine do not reduce noxious stimulus-evoked release of immunoreactive neurokinins in the dorsal horn of the spinal cat.The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats.Spinal antinociceptive actions of mu- and kappa-opioids: the importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulusOn the selectivity of intravenous mu- and kappa-opioids between nociceptive and non-nociceptive reflexes in the spinalized rat.Is the cutaneous silent period an opiate-sensitive nociceptive reflex?Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.Spinal opioid receptor-sensitive muscle afferents contribute to the fatigue-induced increase in intracortical inhibition in healthy humans.Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.Reversible paralysis and loss of deep pain sensation after topical intrathecal morphine administration following durotomy.Identifying the role of group III/IV muscle afferents in the carotid baroreflex control of mean arterial pressure and heart rate during exercise.On the contribution of group III and IV muscle afferents to the circulatory response to rhythmic exercise in humans.Use of epidural analgesia for pain management after major spinal surgery.Effects of centrally acting analgesics on spinal segmental reflexes and wind-up.
P2860
Q26801420-2B1BC8E4-34ED-46E9-9CA6-59112C2D5D5EQ34236432-B8E79200-2B87-4751-90ED-A48272B88866Q35069305-AAD8B419-1B48-4C43-99C5-BBB5C98387DCQ35754296-5DA3BAF9-9AF6-4312-AD37-29ABFE09D075Q35887875-B2F60DD1-B99A-4DFC-B45D-3B7F81715D33Q36962717-363613F8-40EF-49FB-B269-99FC4D28AF46Q37077450-43AD462C-6E4B-47FF-AAF9-55F91D834ABBQ37172821-8B71C81F-F7D8-459A-9476-FC8BA44DD736Q37484043-C59F0E82-0DB7-4F46-BA7D-DD07935F64F4Q37979202-A3B52E27-BE50-4403-BA9D-815C845D39BCQ38090368-B9FC7275-F134-4078-9BEF-CE9045D665CEQ38164950-AE6E8A30-A895-456F-8D06-A6D60158E6AFQ38589027-134D8E37-DAFD-41E9-BA7A-F97694B6C93CQ41912222-B9ECF91D-7083-4734-98E3-34E9860ACEAFQ41995007-654FB77D-AF6A-49CA-A985-9C070C8DB911Q42115852-477B05CF-6D92-4229-B26F-F161CAD0C7D0Q42129312-CD63699A-AA01-41A8-B42F-33D63AA918D4Q42207036-66258DA1-5A81-4B16-9287-1E4C06DC17AFQ42372994-0EFF9E73-174A-4219-B671-9EE724A33B4FQ42463170-98D0088B-4BEE-4A53-896E-165642311417Q42713255-31A9E26D-DCA8-40A7-B0AF-7FD24391D5CAQ42847477-0D316F8E-EA35-4B4C-B46A-F991DD97E790Q42847482-4C84F392-CCEB-44E4-B1BE-240958CDDDEAQ43982822-98F56675-49C2-47A9-A388-EB4BFC4CDA0EQ44344794-163034D3-712B-4153-982A-F6C7F497D23AQ44349428-731AC140-6763-476D-BC9C-8090D8516118Q44351811-A0B9B965-CB8F-4326-9B1A-DEF3DC6A8F78Q47885229-53EC089C-F5FC-4CEA-B8D1-0565C0EDC9E8Q48127365-DF9075EB-BED9-44E6-BB3E-837E8B8DDFC5Q48257462-4BBD25B5-2C8B-4178-94F2-262C6FEBEF22Q48625449-4EAC1774-1FFB-4E65-90AC-D2D933E3B945Q52996667-7FF5E8D2-E418-4D29-A33E-ED07316BC1B6
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
The physiology and pharmacology of spinal opiates.
@en
The physiology and pharmacology of spinal opiates.
@nl
type
label
The physiology and pharmacology of spinal opiates.
@en
The physiology and pharmacology of spinal opiates.
@nl
prefLabel
The physiology and pharmacology of spinal opiates.
@en
The physiology and pharmacology of spinal opiates.
@nl
P1476
The physiology and pharmacology of spinal opiates.
@en
P2093
P304
P356
10.1146/ANNUREV.PA.25.040185.002245
P577
1985-01-01T00:00:00Z